<DOC>
<DOCNO>
EP-0003863
</DOCNO>
<TEXT>
<DATE>
19790905
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/58 A61P-17/00 C07J-71/00 <main>C07J-31/00</main> A61K-31/565 C07J-31/00 
</IPC-CLASSIFICATIONS>
<TITLE>
novel androstadienes, processes for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
scherico ltdch<sep>scherico ltd.<sep>technobiotic ltd.t√∂pferstrasse 5ch-6004 lucernech<sep>scherico ltd.<sep>
</APPLICANT>
<INVENTOR>
green michael j<sep>tiberi robert<sep>green, michael j.<sep>tiberi, robert<sep>green, michael j.33 wheeler roadkendall park new jersey 08824us<sep>tiberi, robert3 woodview driveenglishtown new jersey 07726us<sep>green, michael j.  <sep>tiberi, robert<sep>green, michael j.33 wheeler roadkendall park new jersey 08824us<sep>tiberi, robert3 woodview driveenglishtown new jersey 07726us<sep>
</INVENTOR>
<ABSTRACT>
this invention relates to novel dermatologically active  androstadienes of the formula    wherein m is a benzyl, phenethyl, methylbenzyl, dimethylbenzyl,  chlorobenzyl or dichlorobenzyl group or an alkyl  group having from 1 to 8 carbon atoms,   x is a hydrogen or fluorine atom,   y is an oxygen atom, or, provided that x is a hydrogen atom, y  can also be (h, h),   and n is 1 or 2,   to processes for their preparation, and to pharmaceutical  compositions containing them; and also to related androstadienes  useful as intermediates in their preparation.  the novel compounds of the formula ia can be used in  particular in the treatment of acne.  
</ABSTRACT>
</TEXT>
</DOC>
